Terkko Navigator / Pyrhönen, S.

Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer

Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma

Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels

Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial

Toremifene in the treatment of breast cancer

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer

Prognostic value of bcl-2 expression among women with breast cancer in Libya

ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer

Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma

Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya

Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

Diagnosis delay in Libyan female breast cancer

Prognostic significance of DNA image cytometry in Libyan breast cancer

Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma

Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study

Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathologica

Securin identifies a subgroup of patients with poor outcome in rectal cancer treated with long-course (chemo)radiotherapy

Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab

Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer

Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer

The expression and distribution of group IIA phospholipase A2 in human colorectal tumours

Are immunological treatments beneficial for malignant melanoma of the skin?

NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer

Prognostic evaluation of COX-2 expression in renal cell carcinoma

Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma

Current and predicted cost of metastatic renal cell carcinoma in Finland

Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer

MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer

VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival

Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation

Internet knowledge expectations by radiotherapy patients

Bcl-2 expression significantly correlates with thymidylate synthase expression in colorectal cancer patients

Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer

Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancer